Dihydroartemisinin ameliorates the liver steatosis in metabolic associated fatty liver disease mice by attenuating the inflammation and oxidative stress and promoting autophagy-Reference-Cited by-同舟云学术

Dihydroartemisinin ameliorates the liver steatosis in metabolic associated fatty liver disease mice by attenuating the inflammation and oxidative stress and promoting autophagy

Published:2023 Issue: Volume:38 Page:
ISSN:1678-2674
Container-title:Acta Cirúrgica Brasileira
language:
Short-container-title:Acta Cir. Bras.

Author:

Hu Yiyi¹^ORCID,Peng Xuetao²^ORCID,Du Guoping²^ORCID,Zhai Yingji²^ORCID,Xiong Xingbo²^ORCID,Luo Xiaoliang²^ORCID

Affiliation:

1. Shunde Hospital of Southern Medical University, China; Shunde Hospital of Southern Medical University, China

2. Shunde Hospital of Southern Medical University, China

Publisher

FapUNIFESP (SciELO)

Subject

Surgery

Link

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S0102-86502023000100234&tlng=en

Reference49 articles.

1. Role of toll-like receptors and their downstream molecules in the development of nonalcoholic fatty liver disease;Miura K;Gastroenterol Res Pract,2010

2. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment;Milic S;Dig Dis,2012

3. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome;Lonardo A;Dig Liver Dis,2015

4. Non-alcoholic fatty liver disease;Powell EE;Lancet,2021

5. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon G;Aliment Pharmacol Ther,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydroartemisinin modulated arachidonic acid metabolism and mitigated liver inflammation by inhibiting the activation of 5-LOX and COX-2;Heliyon;2024-07